Company intelligence / Profile preview

Seattle Cancer Care Alliance

Seattle, Washington, United Statesen.wikipedia.org ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Over two decades, SCCA served nearly 190,000 patients and conducted more than 1,700 clinical trials. It was instrumental in advancing new models of cancer care delivery and connecting patients with cutting-edge research.

Therapeutic areas: Oncology
Modalities: Cell therapyBiologicSmall moleculeMonoclonal antibody
Industry: Academic Hospital/University/Research

Drug pipeline

4 assets

doxorubicin

Commercial

Indications: Lymphoma, Soft tissue sarcoma

3 more assets in the full pipeline.

Request access →

Partnerships

UW MedicineSeattle Children’sNetwork affiliations with hospitals in Washington, Alaska, Montana

Beyond the preview

Go deeper on Seattle Cancer Care Alliance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seattle Cancer Care Alliance.

Explore the full profile